产前诊断的貌似孤立性胎儿后颅窝异常的结局:系统综述与Meta分析
该系统综述与Meta分析纳入31项研究、676例产前诊断的貌似孤立性后颅窝异常胎儿,评估遗传学异常、随访影像新发结构异常及神经发育不良结局。孤立性大枕大池或Blake囊肿总体结局良好;Dandy-Walker畸形遗传学异常及神经发育不良风险显著;蚓部发育不良病例数少,尚无法客观评估神经发育延迟负担。
要点
- 孤立性大枕大池:染色体、拷贝数变异及二代测序均无异常,神经发育不良结局4.9%。
- 孤立性Blake囊肿:染色体异常2.7%、CMA检出拷贝数变异2.9%,神经发育不良结局2.0%。
- 孤立性Dandy-Walker畸形:染色体异常10.7%、CMA检出拷贝数变异15.4%、二代测序异常16.5%,神经发育不良结局45.5%。
核心结论
- 当前胎儿后颅窝异常文献仍存在明显不足,主要为缺乏标准化神经发育评估工具及多数纳入研究随访时间异质性。
- 产前诊断的孤立性大枕大池或孤立性Blake囊肿胎儿总体结局良好。
- Dandy-Walker畸形与遗传学异常及神经发育不良结局的显著风险相关,而蚓部发育不良病例数少,尚无法客观评估这些儿童神经发育延迟的实际负担。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库自建库至2024年9月1日。
- 纳入标准为报告产前诊断貌似孤立性后颅窝异常胎儿结局的研究,貌似孤立性指原发诊断时无相关脑或脑外畸形,包括大枕大池、Blake囊肿、Dandy-Walker畸形和蚓部发育不良。
- 共纳入31项研究,包括676例貌似孤立性后颅窝异常且结局已知的胎儿。
- 采用比例随机效应Meta分析合并数据。
主要发现
- 孤立性大枕大池:G显带核型分析未检出染色体异常,CMA未检出拷贝数变异,二代测序未检出异常,随访超声或胎儿MRI未检出相关结构异常,而产前影像未检出、仅生后检出的额外异常占3.5%(95%CI 0.7-8.3%),神经发育不良结局占4.9%(95%CI 1.5-10.0%)。
- 孤立性Blake囊肿:染色体异常占2.7%(95%CI 0.8-5.4%),CMA检出拷贝数变异占2.9%(95%CI 0.5-7.0%),二代测序未检出遗传学异常,胎儿MRI未检出仅MRI发现的额外异常,生后影像检出产前未发现异常占3.2%(95%CI 0.8-7.1%),囊肿宫内消退占42.7%(95%CI 35.7-49.8%),神经发育不良结局占2.0%(95%CI 0.5-4.5%)。
- 孤立性Dandy-Walker畸形:染色体异常占10.7%(95%CI 5.4-17.5%),CMA检出拷贝数变异占15.4%(95%CI 6.2-27.8%),二代测序检出遗传学异常占16.5%(95%CI 4.6-33.8%),仅随访超声和胎儿MRI检出的相关结构异常分别占8.2%(95%CI 0.2-25.6%)和17.3%(95%CI 1.3-45.6%),仅生后影像检出的相关结构异常占11.3%(95%CI 2.4-25.7%),神经发育不良结局占45.5%(95%CI 17.3-75.4%)。
- 孤立性蚓部发育不良:染色体异常占6.0%(95%CI 0.7-15.9%),CMA检出拷贝数变异占15.4%(95%CI 1.0-42.1%),二代测序检出遗传学异常占17.2%(95%CI 3.3-38.9%),随访超声或胎儿MRI未检出仅影像发现的相关结构异常,仅生后影像检出的相关结构异常占18.1%(95%CI 5.4-36.0%),神经发育不良结局占23.6%(95%CI 5.0-50.4%)。
临床怎么用
- 产前诊断孤立性大枕大池或孤立性Blake囊肿的胎儿总体结局良好。
- Dandy-Walker畸形与遗传学异常及神经发育不良结局的显著风险相关。
- 蚓部发育不良病例数少,尚无法客观评估神经发育延迟的实际负担。
- 当前文献缺乏标准化神经发育评估工具,且多数纳入研究随访时间存在异质性。
局限性
- 当前胎儿后颅窝异常文献仍存在明显不足,主要为缺乏标准化神经发育评估工具。
- 多数纳入研究随访时间存在异质性。
- 蚓部发育不良病例数少,尚无法客观评估神经发育延迟的实际负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the outcomes of apparently isolated fetal posterior fossa anomalies diagnosed prenatally. METHODS: MEDLINE, EMBASE and Cochrane databases were searched from inception to 1 September 2024. The inclusion criteria were studies reporting the outcomes of fetuses with a prenatal diagnosis of apparently isolated posterior fossa anomaly, defined as an anomaly with no associated cerebral or extracerebral malformations at the time of the primary diagnosis, including mega cisterna magna (MCM), Blake's pouch cyst (BPC), Dandy-Walker malformation (DWM) and vermian hypoplasia (VH). The outcomes observed were: chromosomal or genetic anomalies; associated structural anomalies detected exclusively on follow-up ultrasound, fetal magnetic resonance imaging (MRI) or postnatal imaging; and adverse neurodevelopmental outcome. Random-effects meta-analyses of proportions were used to combine data. RESULTS: Thirty-one studies (including 676 fetuses with an apparently isolated posterior fossa anomaly and a known outcome) were included. In fetuses with a prenatal diagnosis of isolated MCM, there were no cases of chromosomal anomaly detected on G-banded karyotype analysis, copy number variants (CNVs) detected on chromosomal microarray analysis (CMA), anomalies detected on next generation sequencing (NGS), or associated structural anomalies detected on follow-up ultrasound or fetal MRI, while additional anomalies not detected on prenatal imaging were identified exclusively postnatally in 3.5% (95% CI, 0.7-8.3%) of cases. An abnormal neurodevelopmental outcome was reported in 4.9% (95% CI, 1.5-10.0%) of cases. In fetuses with a prenatal diagnosis of isolated BPC, chromosomal anomaly was reported in 2.7% (95% CI, 0.8-5.4%) of cases and CNVs detected on CMA were reported in 2.9% (95% CI, 0.5-7.0%), while there were no cases of genetic anomaly detected on NGS. There were no cases of additional anomalies detected exclusively on fetal MRI, while on postnatal imaging, 3.2% (95% CI, 0.8-7.1%) of fetuses with a prenatal diagnosis of BPC had an anomaly that was not detected prenatally. In-utero resolution of the cyst was reported in 42.7% (95% CI, 35.7-49.8%) of cases. An abnormal neurodevelopmental outcome was reported in 2.0% (95% CI, 0.5-4.5%) of cases. In fetuses with a prenatal diagnosis of isolated DWM, a chromosomal anomaly was detected in 10.7% (95% CI, 5.4-17.5%) of cases, CNVs were detected on CMA in 15.4% (95% CI, 6.2-27.8%) of cases and genetic anomalies were detected on NGS in 16.5% (95% CI, 4.6-33.8%) of cases. Associated structural anomalies detected exclusively on follow-up ultrasound and fetal MRI were reported in 8.2% (95% CI, 0.2-25.6%) and 17.3% (95% CI, 1.3-45.6%) of cases, respectively, while 11.3% (95% CI, 2.4-25.7%) of fetuses had associated structural anomalies detected only on postnatal imaging. Abnormal neurodevelopmental outcome affected 45.5% (95% CI, 17.3-75.4%) of cases. In fetuses with a prenatal diagnosis of isolated VH, a chromosomal anomaly was reported in 6.0% (95% CI, 0.7-15.9%) of cases, CNVs were detected on CMA in 15.4% (95% CI, 1.0-42.1%) of cases and genetic anomalies were detected on NGS in 17.2% (95% CI, 3.3-38.9%) of cases. There were no cases presenting with associated structural anomalies detected exclusively on follow-up ultrasound or fetal MRI, while 18.1% (95% CI, 5.4-36.0%) of cases had associated structural anomalies detected only on postnatal imaging. An abnormal neurodevelopmental outcome was reported in 23.6% (95% CI, 5.0-50.4%) of cases. CONCLUSIONS: There are still significant weaknesses in the current literature on fetal posterior fossa anomalies, mainly characterized by the lack of standardized tools for neurodevelopmental assessment and the heterogeneity in timing of follow-up for most included studies. Fetuses with a prenatal diagnosis of isolated MCM or isolated BPC have a generally favorable outcome. Conversely, DWM is associated with a significant risk of genetic anomaly and adverse neurodevelopmental outcome, while the small number of cases with VH still precludes an objective evaluation of the actual burden of neurodevelopmental delay in these children. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Parisi N, Rizzo G, Cecchini F, et al. Outcome of apparently isolated fetal posterior fossa anomalies: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2025. PMID: 40785453. doi:10.1002/uog.29309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。